121 related articles for article (PubMed ID: 11558589)
1. Synthesis and cytotoxic activity of benzophenanthrolinone analogues of acronycine.
Bongui JB; Elomri A; Seguin E; Tillequin F; Pfeiffer B; Renard P; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1077-80. PubMed ID: 11558589
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic activity of acronycine analogues in the benzo[c]pyrano[3,2-h]acridin-7-one and naphtho[1,2-b][1,7] and [1,10]-phenanthrolin-7(14H)-one series.
Bongui JB; Elomri A; Cahard D; Tillequin F; Pfeiffer B; Pierré A; Seguin E
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1540-6. PubMed ID: 16327185
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic activity of 11-nitro and 11-amino derivatives of acronycine and 6-demethoxyacronycine.
Elomri A; Michel S; Koch M; Seguin E; Tillequin F; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1604-6. PubMed ID: 10605058
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxic activity of dimeric analogs of acronycine in the benzo[b]pyrano[3,2-h]acridin-7-one series.
Gaslonde T; Michel S; Koch M; Pfeiffer B; Léonce S; Pierré A; Tillequin F
Chem Pharm Bull (Tokyo); 2007 May; 55(5):734-8. PubMed ID: 17473459
[TBL] [Abstract][Full Text] [Related]
5. 2,2-dimethyl-2H-pyran-derived alkaloids I. Practical synthesis of acronycine and benzo[b]acronycine and their biological properties.
Motiur Rahman AF; Liang JL; Lee SH; Son JK; Jung MJ; Kwon Y; Jahng Y
Arch Pharm Res; 2008 Sep; 31(9):1087-93. PubMed ID: 18806949
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
Elomri A; Skaltsounis AL; Michel S; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic activity of pyranophenanthridine analogues of fagaronine and acronycine.
Razafimbelo J; Baudouin G; Tillequin F; Renard P; Léonce S; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):34-41. PubMed ID: 9468635
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine.
Sittisombut C; Boutefnouchet S; Trinh Van-Dufat H; Tian W; Michel S; Koch M; Tillequin F; Pfeiffer B; Pierré A
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1113-8. PubMed ID: 16880654
[TBL] [Abstract][Full Text] [Related]
9. 1-Oxo-2-hydroxy-1,2-dihydroacronycine: a useful synthon in the acronycine series for the introduction of amino substituents at 6-position and for the conversion into isopropylfuroacridones.
Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1304-7. PubMed ID: 11605659
[TBL] [Abstract][Full Text] [Related]
10. [New antitumor agents in the acronycine series].
Tillequin F
Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic activity of benzo[a]acronycine and benzo[b]acronycine substituted on the A ring.
Gaslonde T; Covello F; Velazquez-Alonso L; Léonce S; Pierré A; Pfeiffer B; Michel S; Tillequin F
Eur J Med Chem; 2011 May; 46(5):1861-73. PubMed ID: 21411193
[TBL] [Abstract][Full Text] [Related]
12. [Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents].
Seguin E; Tillequin F
Ann Pharm Fr; 2005 Jan; 63(1):44-52. PubMed ID: 15803100
[TBL] [Abstract][Full Text] [Related]
13. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
Koch M
Bull Acad Natl Med; 2007 Jan; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Pfeiffer B; Renard P; Kraus-Berthier L; Léonce S; Pierré A
Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):293-7. PubMed ID: 14993749
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
Do Q; Thi Mai HD; Gaslonde T; Pfeiffer B; Léonce S; Pierré A; Michel S; Tillequin F; Dufat H
Eur J Med Chem; 2008 Dec; 43(12):2677-87. PubMed ID: 18342404
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of new acronine analogues as suggested by molecular descriptors.
Neto MR; DaCosta JB; Sant'Anna CM; Carneiro JW
Arzneimittelforschung; 2005; 55(5):282-8. PubMed ID: 15960428
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series.
Elomri A; Mitaku S; Michel S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Guilbaud N; Léonce S; Kraus-Berthier L; Rolland Y; Atassi G
J Med Chem; 1996 Nov; 39(24):4762-6. PubMed ID: 8941390
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.
Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Atassi G
J Nat Prod; 1998 Feb; 61(2):198-201. PubMed ID: 9514007
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and cytotoxic activity of Michael acceptors and enol esters in the benzo[b]acronycine series.
Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Bailly C; David-Cordonnier MH; Pfeiffer B; Léonce S; Pierré A
Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):919-22. PubMed ID: 16079520
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-proliferative activity of 2-hydroxy-1,2-dihydroacronycine glycosides.
Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G
Pharm Res; 1996 Jun; 13(6):939-43. PubMed ID: 8792436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
